Taken together, these findings suggested that KPC1 functions as a suppressor of NF-κB pathway in cholangiocarcinoma cells; whereas the KPC1 p.M8V editing confers a loss-of-function effect on this pathway. This evidence concerns the gene NFKB1 and cholangiocarcinoma.